Related Experiment Video
Updated: Jun 13, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Cardiovascular consequences of obese and nonobese obstructive sleep apnea
1Division of Pulmonary, Sleep and Critical Care Medicine, Center for Sleep Medicine, Mayo Clinic, 200 First Street South West, Rochester, MN 55901, USA. ramar.kannan@mayo.edu <ramar.kannan@mayo.edu>
Abstract:
Current evidence suggests a role for obstructive sleep apnea (OSA) in the development of cardiovascular disorders. However, obesity is an active confounder in this relationship. OSA and obesity share similar pathophysiologic mechanisms potentially leading to cardiovascular disorders. Presence of OSA in obese patients may further contribute to adverse cardiovascular outcomes when compared with each condition in isolation. In this review the authors explore the complex relationship between OSA and obesity (and nonobese subjects) in the development of cardiovascular disorders.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Coronary Artery Disease I: Introduction
Heart Failure VI: Adjunct Therapies
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
